Retraction notice to "Maternal Nutrient Restriction Predisposes Ventricular Remodeling in Adult Sheep Offspring" [The Journal of Nutritional Biochemistry 24 (2013) 1258-1265, (S095528631200263X), (10.1016/j.jnutbio.2012.10.001)];Maternal nutrient restriction predisposes ventricular remodeling in adult sheep offspring

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1258-1265

  Ge, Wei ^a,b   Hu, Nan ^b   George, Lindsey A ^c   Ford, Stephen P ^c   Nathanielsz, Peter W ^c,d   Wang, Xiao Ming ^a   Ren, Jun ^a,b,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Center for Cardiovascular Research and Alternative Medicine   (United States)

^c UNIVERSITY OF WYOMING   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Gestation; Insulin signaling; Nutrition restriction; Offspring

Indexed keywords

ADENYLATE KINASE; BECLIN 1; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; INSULIN RECEPTOR SUBSTRATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CALORIC RESTRICTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; MATERNAL NUTRITION; NONHUMAN; PROGENY; SHEEP; UPREGULATION; ANIMAL; HEART VENTRICLE REMODELING; METABOLISM; PREGNANCY; PRENATAL EXPOSURE;

MAMMALIA; OVIS ARIES;

ADENYLATE KINASE; ANIMALS; CALORIC RESTRICTION; CYTOKINES; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INFLAMMATION MEDIATORS; INSULIN RECEPTOR SUBSTRATE PROTEINS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTO-ONCOGENE PROTEINS C-AKT; SHEEP; VENTRICULAR REMODELING;

EID: 84879294068     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2022.109243     Document Type: Erratum

References (29)

1. McMillen I.C., Adams M.B., Ross J.T., Coulter C.L., Simonetta G., Owens J.A., et al. Fetal growth restriction: adaptations and consequences. Reproduction 2001, 122(2):195-204.
2. Symonds M.E., Budge H., Stephenson T., McMillen I.C. Fetal endocrinology and development-manipulation and adaptation to long-term nutritional and environmental challenges. Reproduction 2001, 121(6):853-862.
3. Hales C.N., Barker D.J. The thrifty phenotype hypothesis. Br Med Bull 2001, 60:5-20.
4. Barker D.J., Clark P.M. Fetal undernutrition and disease in later life. Rev Reprod 1997, 2(2):105-112.
5. Godfrey K., Robinson S. Maternal nutrition, placental growth and fetal programming. Proc Nutr Soc 1998, 57(1):105-111.
6. Barker D.J., Gelow J., Thornburg K., Osmond C., Kajantie E., Eriksson J.G. The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur J Heart Fail 2010, 12(8):819-825.
7. Barker D.J. The origins of the developmental origins theory. J Intern Med 2007, 261(5):412-417.
8. Barker D.J. Coronary heart disease: a disorder of growth. Horm Res 2003, 59(Suppl. 1):35-41.
9. Schneider H. Ontogenic changes in the nutritive function of the placenta. Placenta 1996, 17(1):15-26.
10. Bergmann R.L., Bergmann K.E., Dudenhausen J.W. Undernutrition and growth restriction in pregnancy. Nestle Nutr Workshop Ser Pediatr Program 2008, 61:103-121.
11. Green A.S., Rozance P.J., Limesand S.W. Consequences of a compromised intrauterine environment on islet function. J Endocrinol 2010, 205(3):211-224.
12. Fall C. Maternal nutrition: effects on health in the next generation. Indian J Med Res 2009, 130(5):593-599.
13. Dong F., Ford S.P., Fang C.X., Nijland M.J., Nathanielsz P.W., Ren J. Maternal nutrient restriction during early to mid gestation up-regulates cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep. Growth Horm IGF Res 2005, 15(4):291-299.
14. Kim M., Tian R. Targeting AMPK for cardiac protection: opportunities and challenges. J Mol Cell Cardiol 2011, 51(4):548-553.
15. Fritsche L., Weigert C., Haring H.U., Lehmann R. How insulin receptor substrate proteins regulate the metabolic capacity of the liver-implications for health and disease. Curr Med Chem 2008, 15(13):1316-1329.
16. Nair S., Ren J. Autophagy and cardiovascular aging: lesson learned from rapamycin. Cell Cycle 2012, 11(11):2092-2099.
17. Glass C.K., Olefsky J.M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012, 15(5):635-645.
18. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17(1):4-12.
19. George L.A., Zhang L., Tuersunjiang N., Ma Y., Long N.M., Uthlaut A.B., et al. Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring. Am J Physiol Regul Integr Comp Physiol 2012, 302(7):R795-R804.
20. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119(14):1941-1949.
21. Semple D., Smith K., Bhandari S., Seymour A.M. Uremic cardiomyopathy and insulin resistance: a critical role for akt?. J Am Soc Nephrol 2011, 22(2):207-215.
22. Fang C.X., Dong F., Ren B.H., Epstein P.N., Ren J. Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia 2005, 48(11):2412-2421.
23. Balasubramanian S., Johnston R.K., Moschella P.C., Mani S.K., Tuxworth W.J., Kuppuswamy D. mTOR in growth and protection of hypertrophying myocardium. Cardiovasc Hematol Agents Med Chem 2009, 7(1):52-63.
24. Boluyt M.O., Li Z.B., Loyd A.M., Scalia A.F., Cirrincione G.M., Jackson R.R. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 2004, 18(4):257-267.
25. Wang Z.V., Rothermel B.A., Hill J.A. Autophagy in hypertensive heart disease. J Biol Chem 2010, 285(12):8509-8514.
26. Rohini A., Agrawal N., Koyani C.N., Singh R. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 2010, 61(4):269-280.
27. Sriramula S., Haque M., Majid D.S., Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008, 51(5):1345-1351.
28. Ha T., Li Y., Hua F., Ma J., Gao X., Kelley J., et al. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 2005, 68(2):224-234.
29. Nathanielsz P.W. A time to be born: implications of animal studies in maternal-fetal medicine. Birth 1994, 21(3):163-169.